JULÄINE
Commercial- Indications
- Aging
Company intelligence / Profile preview
Nordberg Medical
Swedennordbergmedical.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Nordberg Medical’s flagship product JULÄINE™ is a CE-marked injectable collagen biostimulator based on high-purity poly-L-lactic acid microspheres. Clinical results highlight its ability to stimulate natural collagen production for gradual, long-lasting facial rejuvenation with a strong safety profile and excellent tissue integration[2].
- Therapeutic areas
- OtherDermatology
- Modalities
- DeviceBiomaterial-based medical deviceCollagen biostimulator
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Nordberg Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nordberg Medical.